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ABSTRAK 
Perbandingan Kesan Penambahan Morfin Intratekal Berbanding Dexmedetomidine 
sebagai Pembantu kepada Bupivacaine dalam Pembiusan Spinal untuk Pembedahan 
Ortopedik di Anggota Kaki 
M. Noordin M. Faiz 1, N. M. Nik Abdullah, Mazlan Zulfakar 1 
1Jabatan Anestesiologi dan Rawatan Rapi, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia 
 
Abstrak 
Pengenalan: Kami membandingkan kesan penambahan morfin intratekal berbanding 
dexmedetomidine sebagai pembantu kepada bupivacaine dalam pembedahan ortopedik di 
anggota kaki. Permulaan dan tempoh anestesia tulang belakang dinilai menggunakan 
pemeriksaan klinikal. 
 
Metodologi: Tiga puluh enam pesakit, berumur 18-60 tahun,  diklasifikasikan di bawah 
ASA 1-2, menjalani pembedahan ortopedik anggota kaki di bawah anestesia tulang 
belakang, telah di buat secara rawak kepada dua kumpulan: kumpulan morfin (n = 18) dan 
kumpulan dexmedetomidine (n-18). Anestesia tulang belakang diberikan untuk kumpulan 
masing-masing; 2.5 ml bupivacaine hiperbaric 0.5% dan 5 μg dexmedetomidine dalam 0.5 
ml saline normal atau 2.5 ml 0.5% bupivacaine hyperbaric dengan 0.2 mg morfin dalam 0.5 
ml saline normal. Pengukuran blok deria mengikut tahap dermatom dan skala Bromage 
untuk penilaian motor dan skor sakit pasca pembedahan direkodkan untuk analisis statistik. 
Data telah diuji oleh ujian -t dan analisis ANOVA berulang. 
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Keputusan: Tiada perbezaan masa yang signifikan untuk mencapai T10 antara morfin dan 
dexmedetomidine (p> 0.05). Terdapat perbezaan masa yang signifikan untuk mencapai 
Bromage 3 antara morfin dan dexmedetomidine (p <0.05). Purata (SD) masa untuk 
mencapai Bromage 3 untuk morfin ialah 4.56 (0.78) minit dan untuk dexmedetomidine 
adalah 3.83 (0.79) minit menunjukkan bahawa masa purata mencapai Bromage 3 adalah 
lebih rendah dalam kumpulan dexmedetomidine. Terdapat perbezaan masa yang signifikan 
untuk mencapai Bromage 0 antara kumpulan morfin dan dexmedetomidine (p <0.05). 
Purata (SD) masa untuk mencapai Bromage 0 untuk morfin ialah 134.44 (20.64) minit dan 
untuk dexmedetomidine adalah 276.67 (54.02) minit menunjukkan bahawa masa purata 
mencapai Bromage 0 lebih tinggi dalam dexmedetomidine. Untuk hasil interaksi rawatan 
masa dalam analisis ANOVA berulang, kami mendapati bahawa terdapat perbezaan purata 
yang signifikan dari skor rasa sakit antara kumpulan berdasarkan masa (F = 2.54, p = 
0.031). Skor kesakitan lebih tinggi bagi mereka yang mengambil dexmedetomidine 
berbanding dengan morfin. 
 
Kesimpulan: Dexmedetomidine intratekal secara ketara menyebabkan berpanjangan dalam 
deria dan blok motor berbanding dengan morfin intratekal. Walau bagaimanapun, untuk 
kawalan kesakitan selepas pembedahan morfin intratekal adalah lebih bagus 
 
 
Kata kunci: anestesia tulang belakang, morfin intratekal, dexmedetomidine intratekal, 
ortopedik anggota kaki. 
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ABSTRACT 
Comparing the Effect of Adding Intrathecal Morphine Versus Dexmedetomidine as 
Adjuvant to Bupivacaine in Lower Limb for Orthopaedic Surgery 
 
M. Noordin M.Faiz 1, N. M. Nik Abdullah1, Mazlan Zulfakar 1 
1Department of Anaesthesiology and Intensive Care, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, 
Malaysia 
 
Abstract 
Background: We studied the effect of adding intrathecal morphine versus 
dexmedetomidine as adjuvant to bupivacaine in lower limb orthopaedic surgery. The onset 
and the duration of spinal anaesthesia were assessed using clinical examination. 
 
Methods: Thirty-six patients, aged 18-60 year old, classified under ASA 1-2, who 
underwent elective lower limbs orthopaedic surgery under spinal anaesthesia, were 
randomised into two groups: group morphine (n=18) and group dexmedetomidine (n=18). 
Spinal anaesthesia was performed and in group morphine 2.5 ml of 0.5% hyperbaric 
bupivacaine and 0.2 mg morphine in 0.5 ml of normal saline were administered 
intrathecally. In group dexmedetomidine, 2.5 ml of 0.5% hyperbaric bupivacaine and  5 µg 
dexmedetomidine in 0.5 ml normal saline. Measurement of sensory block according to 
dermatome level, Bromage scale for motor assessment and post operative pain score were 
recorded for statistical analysis. Data were tested by independent t-test and repeated 
measure ANOVA analysis.  
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Results: There was no significant difference with regard to the duration to reach T10 
between morphine and dexmedetomidine (p>0.05). There was a significant difference with 
regard to time (mean) to reach Bromage 3 between morphine and dexmedetomidine 
(p<0.05). The time [mean (SD)] to reach Bromage 3 for morphine was 4.56 (0.78) minutes 
and for dexmedetomidine was 3.83 (0.79) minutes indicating that the time to reach 
Bromage 3 was lower in dexmedetomidine. There was a significant difference with regard 
to time taken to reach Bromage 0 between morphine and dexmedetomidine (p<0.05). The 
[mean (SD)] to reach Bromage 0 for morphine was 134.44 (20.64) minutes and for 
dexmedetomidine was 276.67(54.02) minutes indicating that the time to reach Bromage 0 
was higher in dexmedetomidine. For time-treatment interaction results in repeated measure 
ANOVA analysis, we found that there was a significant difference between pain score of 
groups based on time (F= 2.54, p= 0.031). The mean pain score was higher for those who 
took dexmedetomidine compared to morphine.  
 
Conclusions: Intrathecal dexmedetomidine significantly cause prolonged in sensory and 
motor block in comparison with intrathecal morphine. However for post-operative pain 
control, intrathecal morphine gave better pain control post-operatively 
 
Keywords: spinal anaesthesia, intrathecal morphine, intrathecal dexmedetomidine, 
orthopaedic, lower limb surgery, 
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SECTION 2 
2.0 Introduction 
Spinal anaesthesia is one of the methods of anaesthesia for lower limbs surgeries as 
it is very economical and easy to administer. Many studies have showed concerned 
about prolonging the duration of spinal anaesthesia by adding different adjuvant. One of 
these additives are morphine and dexmedetomidine, which have been proved in many 
studies to prolong the duration of peripheral blocks both in animal and human studies 
(1, 2). This technique  of anaesthesia was first performed by August Bier in Germany in 
1889 and six month later Dr J.B Scldwitch in St Petersburg Russia, reported four cases 
of spinal anaesthesia for lower limbs surgery (3) . 
The commonest drug that is being used for spinal anaesthesia is heavy marcaine 
0.5% and with the dose of 5-20mg. The duration of spinal anaesthesia ranged between 
90-120 minutes (4). By looking at the duration of action of heavy marcaine it is 
relatively short duration and the patient may have poor pain controlled postoperatively. 
There are various factors affecting local anaesthetic potency and its effect. The factors 
include dose, volume, baricity and the amount of adjuvant given. Four factors play 
important role in the uptake of local anaesthetics from the subarachnoid space into 
neuronal tissue, concentration of local anesthetic in CSF, surface area of nerve tissue 
exposed to CSF, lipid content of nerve tissue, and blood flow to nerve tissue (5) . 
Dexmedetomidine is the drugs of choice of our research because it has unique 
anaesthetic properties. Dexmedetomidine is one of the recent drug which acts on α2-
adrenergic receptors in the dorsal horn of the spinal cord to produce analgesic effects, it 
can be added and used as an adjuvant in spinal anaesthesia, prolonging both motor and 
sensory block. Various doses have been tried intrathecally (3, 5, 10μg) with favorable 
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outcomes of prolongation of sensory/motor block with preserved haemodynamics; 
however, the prolonged motor block may not be ideal for ambulatory surgeries(6).  
Intrathecal (IT) opiates are useful options in patients undergoing lower limbs 
surgery especially knee arthroplasty, and can significantly reduce postoperative opioid 
requirements. However, the use of IT morphine may be associated with many side 
effects such as pruritus, urinary retention, nausea and vomiting, and potentially life-
threatening adverse effects i.e. delayed respiratory depression. The hydrophilic 
properties of morphine contribute to both the longevity of its analgesic action and also 
the risk of late respiratory depression due to rostral spread when administered 
intrathecally. Profound late respiratory depression has been reported in a number of 
earlier studies, albeit following larger doses of spinal morphine than is used in current 
practice (7). 
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2.1 Study Protocols 
2.1.1 Background of the study 
Lower limb surgery is one of the most common surgeries in orthopaedic specialty.  
There are various cases that involve lower limbs which include trauma and non trauma. Our 
study involved both groups of patient. One of the limiting factors of spinal anaesthesia is 
short duration of motor and sensory block. Our current practice in HUSM is using heavy 
bupivacaine which has relatively short duration of action. Thus this will be a major problem 
for long duration of orthopeadic surgery. To counter these problems a lot of studies had 
been done to solve this limitation. 
There was a study done in Egypt (2012): Effects of intrathecal bupivacaine–fentanyl 
versus bupivacaine–dexmedetomidine in sixty diabetic surgical patients, who were 
submitted for elective lower limb orthopaedic surgery. Patients were randomly allocated to 
three groups (each group 20 patients). In bupivacaine group the patients received 2.5 ml of 
hyperbaric bupivacaine 0.5% plus 0.5 ml of normal saline, in bupivacaine – fentanyl group, 
the patients received 2.5 ml of hyperbaric bupivacaine 0.5% plus 25 µg fentanyl in 0.5 ml 
of normal saline and in bupivacaine–dexmedetomidine group the patients received 2.5 ml 
of hyperbaric bupivacaine 0.5%, plus 10 µg dexmedetomidine in 0.5 ml of normal saline. 
From this study the result shows the duration of sensory and motor block as well as 
duration of effective analgesia was significantly longer in the bupivacaine–
dexmedetomidine group as compared with both bupivacaine–fentanyl and control 
bupivacaine groups (8). 
In Canada (2013), there was a systematic review and meta-analysis on the  
facilitatory effects of perineural dexmedetomidine on neuraxial and peripheral nerve block, 
from this analysis a total of 516 patients were analysed from nine RCTs. Five trials 
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investigated dexmedetomidine as part of spinal anaesthesia and four as part of a brachial 
plexus (BP) block. Sensory block duration was prolonged by 150 minutes with intrathecal 
dexmedetomidine. Perineural dexmedetomidine used in BP block may prolong the mean 
duration of sensory block by 284 minutes (95% CI: 1, 566, P<0.05), but this difference did 
not reach statistical significance. Motor block duration and time to first analgesic request 
were prolonged for both intrathecal and BP block. Dexmedetomidine produced reversible 
bradycardia in 7% of BP block patients, but no effect on the incidence of hypotension. No 
patients experienced respiratory depression. Dexmedetomidine is a potential LA adjuvant 
that can exhibit a facilitatory effect when administered intrathecally as part of spinal 
anaesthesia or peripherally as part of a BP block (9). 
There was almost similar study done in India (2016), comparing intrathecal 
morphine and intrathecal dexmedetomidine in patients undergoing gynaecological surgeries 
under spinal anaesthesia. This was a prospective, randomised, double-blind study involving 
25 patients in each group. Group morphine received 15 mg of 0.5% hyperbaric bupivacaine 
with 250 μg of morphine while group dexmedetomidine received 15 mg of 0.5% hyperbaric 
bupivacaine with 2.5 μg of dexmedetomidine. Time for first rescue analgesic (P = 0.056) 
and total analgesic demand was similar in both groups. Duration of sensory (P = 0.001) and 
motor (P = 000) block was significantly higher in dexmedetomidine group. Itching was 
noticed in 36% and nausea in 52% of patients in the morphine group, either of which was 
not seen in dexmedetomidine group. This study conclude that intrathecal dexmedetomidine 
produces prolonged motor and sensory blockade without undesirable side effects but 
intraoperative hypotension was more frequent in dexmedetomidine group (10) . 
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2.1.2 Problem Statement and Rationale of Study 
The most common practice of spinal anaesthesia for lower limbs surgery is solely 
using heavy marcaine 0.5 % in our local setting. However we encountered several 
limitations using this local anaesthesia. One of the major limitations is the duration of 
sensory and motor block which only last for 2 hours and may lead to inadequate 
anaesthesia intraoperatively and poor analgesia postoperatively. The consequences of 
inadequate anaesthesia may lead to conversion to general anaesthesia. 
In order to solve this problem we conducted a research, with the aim of prolonging 
sensory and motor block and to improve post operative pain control. We have chosen 
dexmedetomidine as a drug of choice because this drug has good pharmacokinetic and 
pharmacodynamic profile.  
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
 
2.2.2 RESEARCH OBJECTIVES 
The study research objectives are divided into general and specific objectives: 
 
General objective 
The aim of this study is to compare the effect of adding morphine versus 
dexmedetomidine to bupivacaine in prolonging the duration of spinal anaesthesia and 
analgesia in lower limbs operations, and to evaluate for any possible side effects. 
Specific objective 
1. To compare the duration of the sensory block of 2.5 ml 0.5% hyperbaric 
bupivacaine with 0.2 mg morphine intrathecal versus 2.5 ml 0.5% hyperbaric 
bupivacaine and 5 μg dexmedetomidine in 0.5 ml administered intrathecally 
2. To compare the duration of the motor block of 2.5 ml 0.5% hyperbaric bupivacaine 
with 0.2 mg morphine intrathecal versus 2.5 ml 0.5% hyperbaric bupivacaine and 5 
μg dexmedetomidine in 0.5 ml administered intrathecally 
3. To evaluate the presence of possible side effect experiences by study sample  
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2.2.3 RESEARCH HYPOTHESIS 
Null hypothesis 
There are no differences in the addition of morphine versus dexmedetomidine to 
bupivacaine in prolonging the duration of spinal anaesthesia and analgesia in lower limb 
operations.  
Alternative hypothesis 
There are differences in effect of adding morphine versus dexmedetomidine to bupivacaine 
in prolonging the duration of spinal anaesthesia and analgesia in lower limb operations. 
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2.2.4 BENEFITS OF THE STUDY 
i. Improvement in neuraxial anaesthesia technique with drug adjuvant and to minimise 
the conversion to general anaesthesia. 
ii. Improvement in patient satisfaction particularly in relation to post operative pain 
relief. 
 
2.2.5 LIMITATIONS OF THE STUDY 
i. Inadequate time to observe and clinical assessment in operating theatre recovery 
particularly for dexmedetomidine group. 
ii. This study can only representative anaesthetic management of patient in Hospital 
Universiti Sains Malaysia (HUSM) as it is not representing the people in Kelantan. 
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2.2.6 METHODOLOGY 
 
2.2.6.1 RESEARCH DESIGN 
This is a prospective, randomized controlled double-blinded study in Trauma 
Operation Theatre and General Operation Theatre of Hospital Universiti Sains Malaysia 
(HUSM). Study period was from February 2017 to February 2018. 
Reference population involved patients scheduled for elective lower limbs 
orthopaedic surgery in HUSM. This research was done in a single phase which involved 
data collection and thesis writing. Following completion of the data collection, analysis 
of the data available was done and compiled in a thesis.  
 
2.2.6.2 SAMPLE SIZE CALCULATION 
The sample size was calculated based on objective 1 and 2, using power and 
sample software version 3.1.2, with the information from previous study, comparative 
evaluation of intrathecal morphine and intrathecal dexmedetomidine in patients 
undergoing gynaecological surgeries under spinal anaesthesia by Pranjali et al., 2016. 
For objective 1 
1. To compare the duration of the sensory block of 2.5 ml 0.5% hyperbaric 
bupivacaine with 0.2 mg morphine intrathecal versus 2.5 ml 0.5% hyperbaric 
bupivacaine and 5 μg dexmedetomidine in 0.5 ml administered intrathecally. 
We are planning a study of a continuous response variable from independent control 
and experimental subjects with 1 control(s) per experimental subject.  In a previous 
study the response within each subject group was normally distributed with standard 
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deviation 61.  If the true difference in the experimental and control means is 63, we 
need to study 16 experimental subjects and 16 control subjects to be able to reject the 
null hypothesis that the population means of the experimental and control groups are 
equal with probability (power) 0.8.   The Type I error probability associated with this 
test of this null hypothesis is 0.05. 
For objective 2 
1. To compare the duration of the motor block of 2.5 ml 0.5% hyperbaric 
bupivacaine with 0.2 mg morphine intrathecal versus 2.5 ml 0.5% hyperbaric 
bupivacaine and 5 μg dexmedetomidine in 0.5 ml administered intrathecally. 
We are planning a study of a continuous response variable from independent control 
and experimental subjects with 1 control(s) per experimental subject.  In a previous 
study the response within each subject group was normally distributed with standard 
deviation 126.62.  If the true difference in the experimental and control means is 176, 
we need to study 9 experimental subjects and 9 control subjects to be able to reject the 
null hypothesis that the population means of the experimental and control groups are 
equal with probability (power) 0.8.   The Type I error probability associated with this 
test of this null hypothesis is 0.05. 
The highest value of estimated sample size is: 36 samples (16x2) + 10% dropout) 
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2.2.6.3 SAMPLING METHOD 
For this research, random sampling was used from the source population as mentioned 
before. 
 
2.2.6.4 INCLUSION AND EXCLUSION CRITERIA 
 
INCLUSION CRITERIA: 
1. Consented patient 
2. ASA 1 - ASA 2 patient. 
3. Patient age: more than 18 years old and less than 60 years old. 
4. Haemodynamically stable patient (stable blood pressure and heart rate). 
5. Expected duration of surgery of less than 2 hours 
6. All orthopaedic elective surgeries involve lower limbs including trauma and non- 
trauma cases. 
EXCLUSION CRITERIA; 
1. Patient refusal to spinal anaesthesia. 
2. Allergy to dexmedetomidine/morphine and local anaesthesia. 
3. Pregnancy. 
4. History of previous spine injury. 
5. History of chronic pain, those that was treated with chronic analgesic medication. 
6. Coagulapathy.  
7. Systemic infection or local infection at site of the injection. 
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8. Patients with history of long-term steroid therapy. 
 
WITHDRAWAL CRITERIA 
1. Patient developed local anaesthetic toxicity. 
2. Patient developed haemodynamic instability (bradycardia/hypotension). 
3. Patient developed anaphylaxis. 
 
DATA COLLECTION 
 Sample was obtained from Trauma operation Theatre (TOT) and General Operation 
Theatre (GOT) HUSM in stipulated time by means of universal sampling. Consent was 
taken from sample that was undergoing elective lower limbs surgery. Sampling 
randomization was done using ‘RESEACHERS RANDOMIZATION SOFTWARE’. The 
consented patients were randomized into two arms group morphine and group 
dexmedetomidine. The card was put inside the box. One card was randomly taken each 
time by nurse that assists spinal anaesthesia.  
 The elective orthopaedic patients who meet the study criteria were approached to 
participate in this study. Each patient was given a thorough explanation along with a copy 
of patient information sheet. All questions were answered to their satisfaction before 
consent was obtained by signing the consent form. 
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RESEARCH TOOL 
1. Drugs study: morphine and dexmedetomidine. 
2. Diluted intravenous atropine (0.2 mg/ml) in 5 mls syringe (to standby at 
patient’s bedside in case of symptomatic bradycardia). Ephedrine 6mg/ml 
diluted in 5ml normal saline. Thiopentone 25mg/ml in 10 ml normal saline 
also prepared for patient who failed spinal anaesthesia as an induction agent 
or as an anti-convulsion if patient develop seizure due to local anaesthetic 
toxicity. 
3. Spinocan 25 G for spinal anaesthesia. 
4. Short bevel needle for sensory assessment during intraoperative. 
5. Bromage score for motor assessment, Ramsay scale for sedation scoring and 
for postoperative pain assessment using visual analogue scale. 
6. Standard monitoring devices that already available at study area to monitor 
patient’s haemodynamic parameters. 
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METHODOLOGY 
1. Approval for Ethics Committee of Universiti Sains Malaysia (USM) was obtained 
before enrollment of the patients.  
2. Eligibility for the patients was screened during preoperative assessment. Written 
consent was obtained from all selected patients that fulfill the inclusion and the 
exclusion criteria.  
3. Premedication was not prescribed in the morning of the surgery and patients were 
randomized using computer generated randomization. 
4. Upon arrival in the OT, all patients were monitored based on standard anaesthesia 
monitoring (non invasive blood pressure, pulse oximetry (spO2), electrocardiography 
(ECG) and baseline BP, HR were documented before the procedures.  
5. IV excess at least 20 G was inserted on the other hand. 
6. IV loading with Ringer’s Lactate solution 10 ml/kg was given before performing the 
block.  
7. Spinal anaesthesia was performed in the operating theatre.  
8. Drugs regime for spinal anaesthesia was prepared:  
• 2 ml of lignocaine 2% for skin infiltration  
• 2.5 ml of 0.5% hyperbaric bupivacaine with 0.2 mg morphine in 0.5 ml of 
normal saline ----- Group M 
• 2.5 ml of 0.5% hyperbaric bupivacaine and 5 μg dexmedetomidine in 0.5 ml of 
normal saline ---Group D 
9. Other standard equipments were used for the block:  
• Spinocan 25G  
